Cognetivity Neurosciences Ltd.
CGN
CNSX
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -11.15% | -17.40% | -32.75% | 53.56% | 71.91% |
| Total Depreciation and Amortization | 4.08% | 7.55% | 0.00% | -40.98% | -7.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,272.28% | 758.77% | 1,292.51% | 8.90% | -101.42% |
| Change in Net Operating Assets | -54.72% | -107.62% | 61.46% | -110.87% | -36.15% |
| Cash from Operations | 107.40% | -89.85% | 61.45% | -117.22% | 78.40% |
| Capital Expenditure | -- | 121.05% | 94.84% | 99.51% | 106.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -35.64% | 63.85% | 83.85% | -98.02% | 84.49% |
| Cash from Investing | -48.91% | 76.79% | 89.24% | -97.80% | 88.47% |
| Total Debt Issued | -- | -- | -- | -143.47% | -99.35% |
| Total Debt Repaid | -5,900.00% | -3,866.67% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.26% | -107.25% | -- | -110.67% | 505.89% |
| Foreign Exchange rate Adjustments | 80.00% | -463.64% | 320.00% | 33.33% | 68.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.32% | -218.66% | -28.76% | -239.30% | 1,023.27% |
